Skip to main content
All lobbying filings

THE NICKLES GROUP, LLC

THE NICKLES GROUP, LLC filed a Q2 report for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) on July 20, 2026, reporting $60,000 in lobbying income.

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Biotechnology advocacy organization.

All filings by THE NICKLES GROUP, LLC · Everything BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Health Issues

Issues related to pharmacy benefit management reforms. Issues related to vaccine policy. Issues related to the medical countermeasures.

Medicare/Medicaid

Issues related to Most Favored Nation drug pricing.

Trade (domestic/foreign)

Issues related to tariffs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem